5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
+58.74%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$447M
AUM Growth
+$447M
(+18%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-24.1%
Top 10 Holdings %
Top 10 Hldgs %
68.5%
Holding
29
New
4
Increased
4
Reduced
6
Closed
3
Top Buys
| 1 |
Praxis Precision Medicines
PRAX
|
$20.7M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$14.1M |
| 3 |
SLN
Silence Therapeutics
SLN
|
$10.3M |
| 4 |
Adverum Biotechnologies
ADVM
|
$7.66M |
| 5 |
Tyra Biosciences
TYRA
|
$6.3M |
Top Sells
| 1 |
Q32 Bio
QTTB
|
$73M |
| 2 |
Viking Therapeutics
VKTX
|
$28.5M |
| 3 |
Enliven Therapeutics
ELVN
|
$23.3M |
| 4 |
Disc Medicine
IRON
|
$17M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$11.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cidara Therapeutics
CDTX
$1.66B
| $1.04M | 0.23% |
1,134,511
| – | – |
|
|
27
Disc Medicine
IRON
$2.07B
| – | – |
-294,221
| Closed | -$17M |
|
|
SPRB
28
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| – | – |
-2,364,000
| Closed | -$6.93M |
|
|
MRTX
29
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-192,500
| Closed | -$11.3M |
|